Adipocyte Lipolysis-Stimulated Interleukin-6 Production Requires Sphingosine Kinase 1 Activity.

Wenliang Zhang,Emilio P. Mottillo,Jiawei Zhao,Allison Gartung,Garrett C. Vanhecke,Jen-Fu Lee,Krishna R. Maddipati,Haiyan Xu,Young-Hoon Ahn,Richard L. Proia,James G. Granneman,Menq-Jer Lee
DOI: https://doi.org/10.1074/jbc.m114.601096
IF: 5.485
2014-01-01
Journal of Biological Chemistry
Abstract:Adipocyte lipolysis can increase the production of inflammatory cytokines such as interleukin-6 (IL-6) that promote insulin resistance. However, the mechanisms that link lipolysis with inflammation remain elusive. Acute activation of β3-adrenergic receptors (ADRB3) triggers lipolysis and up-regulates production of IL-6 in adipocytes, and both of these effects are blocked by pharmacological inhibition of hormone-sensitive lipase. We report that stimulation of ADRB3 induces expression of sphingosine kinase 1 (SphK1) and increases sphingosine 1-phosphate production in adipocytes in a manner that also depends on hormone-sensitive lipase activity. Mechanistically, we found that adipose lipolysis-induced SphK1 up-regulation is mediated by the c-Jun N-terminal kinase (JNK)/activating protein-1 signaling pathway. Inhibition of SphK1 by sphingosine kinase inhibitor 2 diminished the ADRB3-induced IL-6 production both in vitro and in vivo. Induction of IL-6 by ADRB3 activation was suppressed by siRNA knockdown of Sphk1 in cultured adipocytes and was severely attenuated in Sphk1 null mice. Conversely, ectopic expression of SphK1 increased IL-6 expression in adipocytes. Collectively, these data demonstrate that SphK1 is a critical mediator in lipolysis-triggered inflammation in adipocytes.
What problem does this paper attempt to address?